MARSHALL WACE, LLP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$251,422
+4.3%
6,182
+2.3%
0.00%
Q4 2021$241,000
+7.1%
6,0420.0%0.00%
-100.0%
Q3 2021$225,000
-11.8%
6,0420.0%0.00%0.0%
Q2 2021$255,000
-87.3%
6,042
-85.7%
0.00%
-88.9%
Q1 2021$2,001,000
+43.6%
42,257
+41.8%
0.01%0.0%
Q3 2020$1,393,000
-20.6%
29,800
-13.8%
0.01%
-25.0%
Q2 2020$1,754,000
+37.1%
34,576
+29.9%
0.01%
+33.3%
Q4 2019$1,279,000
-83.9%
26,615
-88.7%
0.01%
-85.5%
Q3 2019$7,933,000
+801.5%
234,556
+815.1%
0.06%
+588.9%
Q4 2018$880,000
+28.7%
25,632
+26.4%
0.01%
-10.0%
Q2 2018$684,000
-52.5%
20,278
-54.3%
0.01%
-28.6%
Q4 2015$1,439,000
+82.8%
44,410
+50.6%
0.01%
+40.0%
Q3 2015$787,000
-6.4%
29,484
+68.7%
0.01%
-9.1%
Q2 2015$841,000
-34.5%
17,475
-17.2%
0.01%
-35.3%
Q1 2015$1,284,000
+19.1%
21,095
+1.3%
0.02%
+21.4%
Q4 2014$1,078,000
+220.8%
20,817
+172.8%
0.01%
+180.0%
Q3 2014$336,0007,6310.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Ayer Capital Management, LP 416,666$7,153,00038.92%
Novo Holdings A/S 747,359$11,210,0002.78%
Bain Capital Public Equity Management, LLC 2,333,333$50,073,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 845,027$18,134,0000.84%
HealthCor Management, L.P. 732,200$15,713,0000.84%
RA Capital Management 300,000$6,438,0000.67%
Catalyst Capital Advisors LLC 30,666$658,0000.36%
CR Intrinsic Investors, LLC 119,237$2,559,0000.08%
Weiss Multi-Strategy Advisers LLC 284,130$6,098,0000.07%
SECTORAL ASSET MANAGEMENT INC 57,519$1,234,0000.06%
View complete list of PTC THERAPEUTICS INC shareholders